RVMD · Insider trading · 13F holders · Congress trades
Revolution Medicines, Inc. (RVMD)
Who is buying and selling RVMD: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 107
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $78.4M
- Congress trades, 12 months
- 0
RVMD at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 9 RVMD insiders filed 19 sales worth $78.4M on SEC Form 4, and no open-market purchases; 19 of the sales were pre-planned under Rule 10b5-1.
- 107 13F filers hold RVMD among their 50 largest positions, worth $20.0B combined, including Julian and Felix Baker, James Flynn, Behzad Aghazadeh and Stanley Druckenmiller. The biggest bets by portfolio weight are Nextech Invest Ltd. (67.6%), MIC Capital Management UK LLP (25.3%) and Casdin Capital, LLC (24.2%). In their latest 13Fs, 6 managers opened a new position and 17 added to one.
- No member of Congress has disclosed a trade in RVMD.
- RVMD last closed at $190.27 on Oct 29, 2026.
RVMD insider trading
Between Aug 1, 2026 and Oct 29, 2026, 9 RVMD insiders filed 19 sales worth $78.4M on SEC Form 4, and no open-market purchases; 19 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | Mancini Anthony | See Remarks | Sale10b5-1 | 2,310 | $186.99 | $432K | SEC |
| Oct 1, 2026 | Sandler Alan B. | Chief Development Officer | Sale10b5-1 | 6,309 | $202.14 | $1.3M | SEC |
| Sep 29, 2026 | Cislini Jeff | SVP & General Counsel | Sale10b5-1 | 765 | $207.32 | $159K | SEC |
| Sep 28, 2026 | Mancini Anthony | See Remarks | Sale10b5-1 | 3,708 | $200.45 | $743K | SEC |
| Sep 24, 2026 | Anderson Elizabeth M | Director | Sale10b5-1 | 10,143 | $193.04 | $2.0M | SEC |
| Sep 22, 2026 | Mancini Anthony | See Remarks | Sale10b5-1 | 1,764 | $196.94 | $347K | SEC |
| Sep 18, 2026 | Goldsmith Mark A | See Remarks, Director | Sale10b5-1 | 13,988 | $199.24 | $2.8M | SEC |
| Sep 18, 2026 | Kelsey Stephen Michael | See Remarks | Sale10b5-1 | 5,569 | $199.24 | $1.1M | SEC |
| Sep 18, 2026 | Horn Margaret A | Chief Operating Officer | Sale10b5-1 | 4,967 | $199.24 | $990K | SEC |
| Sep 18, 2026 | Anders Jack | Chief Financial Officer | Sale10b5-1 | 4,053 | $199.24 | $808K | SEC |
| Sep 18, 2026 | Cislini Jeff | SVP & General Counsel | Sale10b5-1 | 3,366 | $199.24 | $671K | SEC |
| Sep 18, 2026 | Mancini Anthony | See Remarks | Sale10b5-1 | 1,774 | $199.24 | $353K | SEC |
| Sep 18, 2026 | Sandler Alan B. | Chief Development Officer | Sale10b5-1 | 341 | $199.24 | $68K | SEC |
| Sep 15, 2026 | Kelsey Stephen Michael | See Remarks | Sale10b5-1 | 92,531 | $202.36 | $18.7M | SEC |
| Sep 14, 2026 | Mancini Anthony | See Remarks | Sale10b5-1 | 15,448 | $204.16 | $3.2M | SEC |
| Sep 10, 2026 | Kim Lorence H. | Director | Sale10b5-1 | 17,090 | $209.82 | $3.6M | SEC |
| Sep 2, 2026 | Kim Lorence H. | Director | Sale10b5-1 | 56,000 | $203.24 | $11.4M | SEC |
| Aug 25, 2026 | Goldsmith Mark A | See Remarks, Director | Sale10b5-1 | 86,000 | $209.20 | $18.0M | SEC |
| Aug 25, 2026 | Cislini Jeff | General Counsel | Sale10b5-1 | 56,894 | $209.24 | $11.9M | SEC |
Who owns RVMD? Hedge funds and superinvestors
107 13F filers hold RVMD among their 50 largest positions, worth $20.0B combined, including Julian and Felix Baker, James Flynn, Behzad Aghazadeh and Stanley Druckenmiller. The biggest bets by portfolio weight are Nextech Invest Ltd. (67.6%), MIC Capital Management UK LLP (25.3%) and Casdin Capital, LLC (24.2%). In their latest 13Fs, 6 managers opened a new position and 17 added to one.
Superinvestors holding RVMD: Julian and Felix Baker 10.8% · James Flynn 5.6% · Behzad Aghazadeh 3.9% · Stanley Druckenmiller 1.7% · Joseph Edelman 1.5%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Farallon Capital Management, L.l.c.Hedge fund | 15.0% | $2.5B | 13,550,796 | -0.4% shares | Q2 2026 |
| Julian and Felix BakerHedge fund | 10.8% | $2.1B | 11,443,357 | +19.8% shares | Q2 2026 |
| Darwin Global Management, Ltd.Hedge fund | 54.5% | $2.0B | 10,629,822 | +380.8% shares | Q2 2026 |
| Jupiter Topco LLCInvestment manager | 0.8% | $2.0B | 10,736,145 | — | Q2 2026 |
| Nextech Invest Ltd.Hedge fund | 67.6% | $1.4B | 7,601,087 | +0.0% shares | Q2 2026 |
| Paradigm Biocapital Advisors LPHedge fund | 22.3% | $1.2B | 6,361,323 | -4.4% shares | Q2 2026 |
| Janus Henderson Group PLCInvestment manager | 0.5% | $949.5M | 9,766,496 | -20.6% shares | Q1 2026 |
| Bvf Inc/ilInvestment manager | 14.2% | $555.3M | 2,965,160 | +3.8% shares | Q2 2026 |
| Alphabet Inc.Corporation | 0.6% | $551.8M | 2,946,619 | -10.5% shares | Q2 2026 |
| Casdin Capital, LLCHedge fund | 24.2% | $482.7M | 2,577,333 | +0.0% shares | Q2 2026 |
| James FlynnHedge fund | 5.6% | $448.0M | 2,392,000 | +4.1% shares | Q2 2026 |
| Assenagon Asset Management S.A.Asset manager | 0.4% | $447.7M | 2,181,185 | — | Q3 2026 |
| Behzad AghazadehHedge fund | 3.9% | $430.2M | 2,297,000 | -2.0% shares | Q2 2026 |
| Nearwater Capital Markets, LtdAsset manager | 6.8% | $392.7M | 2,097,000 | +209.3% shares | Q2 2026 |
| Woodline Partners LPHedge fund | 1.2% | $375.1M | 2,002,863 | -20.1% shares | Q2 2026 |
| Caligan Partners LPHedge fund | 17.7% | $367.4M | 1,961,795 | +18.7% shares | Q2 2026 |
| Integral Health Asset Management, LLCHedge fund | 11.5% | $280.9M | 1,500,000 | +0.0% shares | Q2 2026 |
| Holocene Advisors, LPHedge fund | 0.6% | $254.6M | 1,359,269 | -44.9% shares | Q2 2026 |
| Rock Springs Capital Management LPHedge fund | 10.1% | $207.0M | 1,105,210 | -8.6% shares | Q2 2026 |
| Bellevue Group AGInvestment manager | 4.1% | $196.3M | 1,048,014 | -32.1% shares | Q2 2026 |
| a16z Capital Management, L.L.C.Hedge fund | 1.2% | $172.5M | 921,099 | +0.0% shares | Q2 2026 |
| Siren, L.L.C.Investment manager | 3.4% | $168.6M | 900,000 | -19.0% shares | Q2 2026 |
| Logos Global Management LPHedge fund | 5.6% | $131.1M | 700,000 | -65.0% shares | Q2 2026 |
| DAFNA Capital Management LLCHedge fund | 20.1% | $105.4M | 562,630 | -3.1% shares | Q2 2026 |
| Candriam S.C.A.Hedge fund | 0.5% | $104.1M | 556,392 | — | Q2 2026 |
| MIC Capital Management UK LLPHedge fund | 25.3% | $99.6M | 531,733 | -33.2% shares | Q2 2026 |
| Joseph EdelmanHedge fund | 1.5% | $98.8M | 527,600 | +104.0% shares | Q2 2026 |
| Boxer Capital Management, LLCHedge fund | 7.1% | $93.6M | 500,000 | +0.0% shares | Q2 2026 |
| Mpm Bioimpact LLCHedge fund | 5.6% | $92.2M | 492,483 | -2.8% shares | Q2 2026 |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.Investment manager | 4.9% | $89.7M | 479,080 | +0.0% shares | Q2 2026 |
The 30 largest of 107 positions, by value. Each manager counts with its latest 13F (Q3 2026: 16, Q2 2026: 87, Q1 2026: 4). Screen RVMD in the grand portfolio →
RVMD stock trades by members of Congress
No member of Congress has disclosed a trade in RVMD.
Analysis mentioning RVMD
Posts from the blog that cover Revolution Medicines, Inc., newest first.
RVMD questions and answers
Are insiders buying RVMD stock?
Between Aug 1, 2026 and Oct 29, 2026, 9 RVMD insiders filed 19 sales worth $78.4M on SEC Form 4, and no open-market purchases; 19 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own RVMD?
107 13F filers hold RVMD among their 50 largest positions, worth $20.0B combined, including Julian and Felix Baker, James Flynn, Behzad Aghazadeh and Stanley Druckenmiller. The biggest bets by portfolio weight are Nextech Invest Ltd. (67.6%), MIC Capital Management UK LLP (25.3%) and Casdin Capital, LLC (24.2%). In their latest 13Fs, 6 managers opened a new position and 17 added to one.
Has Congress traded RVMD?
No member of Congress has disclosed a trade in RVMD.
Who is the largest holder of RVMD?
Among 13F filers, Farallon Capital Management, L.l.c. reports the largest RVMD position, $2.5B (13,550,796 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Nextech Invest Ltd.'s: 67.6% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.